ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · IEX Real-Time Price · USD
5.19
+0.58 (12.58%)
At close: May 1, 2024, 4:30 PM
5.24
+0.05 (0.96%)
Pre-market: May 2, 2024, 8:00 AM EDT
ProPhase Labs Revenue
In the year 2023, ProPhase Labs had annual revenue of $44.38M, a decrease of -63.81%. Revenue in the quarter ending December 31, 2023 was $3.50M, a -83.97% decrease year-over-year.
Revenue (ttm)
$44.38M
Revenue Growth
-63.81%
P/S Ratio
2.11
Revenue / Employee
$392,779
Employees
113
Market Cap
93.65M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 44.38M | -78.26M | -63.81% |
Dec 31, 2022 | 122.65M | 43.61M | 55.17% |
Dec 31, 2021 | 79.04M | 64.53M | 444.59% |
Dec 31, 2020 | 14.51M | 4.64M | 46.96% |
Dec 31, 2019 | 9.88M | -3.25M | -24.76% |
Dec 31, 2018 | 13.13M | 3.26M | 33.03% |
Dec 31, 2017 | 9.87M | 5.66M | 134.59% |
Dec 31, 2016 | 4.21M | 1.69M | 67.04% |
Dec 31, 2015 | 2.52M | -19.55M | -88.59% |
Dec 31, 2014 | 22.07M | -2.96M | -11.83% |
Dec 31, 2013 | 25.03M | 2.63M | 11.72% |
Dec 31, 2012 | 22.41M | 4.95M | 28.38% |
Dec 31, 2011 | 17.45M | 2.95M | 20.35% |
Dec 31, 2010 | 14.50M | -5.31M | -26.82% |
Dec 31, 2009 | 19.82M | -691.00K | -3.37% |
Dec 31, 2008 | 20.51M | -7.73M | -27.39% |
Dec 31, 2007 | 28.24M | 1.39M | 5.18% |
Dec 31, 2006 | 26.85M | -26.81M | -49.96% |
Dec 31, 2005 | 53.66M | 9.71M | 22.09% |
Dec 31, 2004 | 43.95M | 2.45M | 5.90% |
Dec 31, 2003 | 41.50M | 12.08M | 41.05% |
Dec 31, 2002 | 29.42M | 6.65M | 29.20% |
Dec 31, 2001 | 22.77M | 7.25M | 46.66% |
Dec 31, 2000 | 15.53M | -6.79M | -30.44% |
Dec 31, 1999 | 22.32M | -14.03M | -38.60% |
Dec 31, 1998 | 36.35M | -33.82M | -48.19% |
Dec 31, 1997 | 70.17M | 69.12M | 6,585.90% |
Sep 30, 1996 | 1.05M | 547.66K | 109.12% |
Sep 30, 1995 | 501.90K | 425.00K | 552.61% |
Sep 30, 1994 | 76.91K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Burning Rock Biotech | 75.80M |
Protalix BioTherapeutics | 65.49M |
BrainsWay | 31.79M |
Forian | 20.48M |
Milestone Pharmaceuticals | 1.00M |
Genelux | 170.00K |
PRPH News
- 7 days ago - ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 - GlobeNewsWire
- 16 days ago - ProPhase Labs Unveils Project ZenQ-AI - GlobeNewsWire
- 22 days ago - ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024 - GlobeNewsWire
- 4 weeks ago - ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives - GlobeNewsWire
- 7 weeks ago - PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024 - GlobeNewsWire
- 2 months ago - ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir - GlobeNewsWire
- 3 months ago - Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts - GlobeNewsWire